tizanidine hydrochloride
NDC 0591-2788, tizanidine hydrochloride, capsule, gelatin coated, from Actavis Pharma, Inc..
- Product NDC
- 0591-2788
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021447
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2788 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2788-86 | 00591278886 | 150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2788-86) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cb8b01b3-bcec-4762-9d67-0db018ef6b22NADAC price for package 00591278886
GET /v1/drugs/nadac/00591278886
Use it
Look up 0591-2788 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2788 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2788. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.